Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Extremely Premature Infants: a Prospective Observational Study

NCT06683677 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT06683677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Extremely Premature Infants: a Prospective Observational Study
Lead sponsor
Charles University, Czech Republic
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
July 1, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high flow nasal canula, premature infant, ventilation therapy